A voxel-based morphometry study of disease severity correlates in relapsing- remitting multiple sclerosis

Multiple Sclerosis

Volumn 16, Issue 1, 2010, Pages 45-54

  Prinster, A ^a,b   Quarantelli, M ^a   Lanzillo, R ^c,d   Orefice, G ^c   Vacca, G ^c   Carotenuto, B ^c   Alfano, B ^a   Brunetti, A ^c   Brescia Morra, V ^c   Salvatore, M ^c  

^a CNR   (Italy)

^b IRCCS SDN   (Italy)

^c University 'Federico '   (Italy)

^d Hermitage Hospital   (Italy)

Author keywords

Cortical atrophy; Expanded Disability Status Scale; Lesion load; Multiple sclerosis; Relapsing remitting; Voxel based morphometry

Indexed keywords

ADULT; ARTICLE; BRAIN ATROPHY; CAUDATE NUCLEUS; CINGULATE GYRUS; CONTROLLED STUDY; CORPUS CALLOSUM; DISEASE DURATION; DISEASE SEVERITY; EXPANDED DISABILITY STATUS SCALE; FEMALE; GRAY MATTER; HUMAN; INSULA; MAJOR CLINICAL STUDY; MALE; MOTONEURON; MOTOR CORTEX; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PARIETAL LOBE; PHYSICAL DISABILITY; PYRAMIDAL TRACT; SENSORIMOTOR CORTEX; TEGMENTUM; TEMPORAL CORTEX; WHITE MATTER;

ADOLESCENT; ADULT; BRAIN; BRAIN MAPPING; CLUSTER ANALYSIS; DATA INTERPRETATION, STATISTICAL; DISABILITY EVALUATION; FEMALE; FUNCTIONAL LATERALITY; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; YOUNG ADULT;

EID: 73949102202     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/1352458509351896     Document Type: Article

References (32)

1. Prinster A., Quarantelli M., Orefice G., et al. Grey matter loss in relapsing-remitting multiple sclerosis: a voxel-based morphometry study. Neuroimage 2006 ; 29: 859-867.
2. Sailer M., Fischl B., Salat D., et al. Focal thinning of the cerebral cortex in multiple sclerosis. Brain 2003 ; 126: 1734-1744. (Pubitemid 36917333)
3. Audoin B., Davies GR, Finisku L., Chard DT, Thompson AJ, Miller DH Localization of grey matter atrophy in early RRMS: A longitudinal study. J Neurol 2006 ; 253: 1495-1501.
4. Charil A., Dagher A., Lerch JP, Zijdenbos AP, Worsley KJ, Evans AC Focal cortical atrophy in multiple sclerosis: relation to lesion load and disability. Neuroimage 2007 ; 34: 509-517.
5. Chen JT, Narayanan S., Collins DL, Smith SM, Matthews PM, Arnold DL Relating neocortical pathology to disability progression in multiple sclerosis using MRI. Neuroimage 2004 ; 23: 1168-1175.
6. Ceccarelli A., Rocca MA, Pagani E., et al. A voxel-based morphometry study of grey matter loss in MS patients with different clinical phenotypes. Neuroimage 2008 ; 42: 315-322.
7. Bendfeldt K., Kuster P., Traud S., et al. Association of regional gray matter volume loss and progression of white matter lesions in multiple sclerosis - A longitudinal voxel-based morphometry study. Neuroimage 2009 ; 45: 60-67.
8. Chard DT, Griffin CM, Parker GJ, Kapoor R., Thompson AJ, Miller DH Brain atrophy in clinically early relapsing- remitting multiple sclerosis. Brain 2002 ; 125: 327-337.
9. Ge Y., Grossman RI, Udupa JK, Babb JS, Nyul LG, Kolson DL Brain atrophy in relapsing-remitting multiple sclerosis: fractional volumetric analysis of gray matter and white matter. Radiology 2001 ; 220: 606-610. (Pubitemid 32799964)
10. Ashburner J., Friston KJ Voxel-based morphometry - the methods. Neuroimage 2000 ; 11: 805-821.
11. Poser CM, Paty DW, Scheinberg L., et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983 ; 13: 227-231.
12. Lublin FD, Reingold SC Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology 1996 ; 46: 907-911.
13. Kurtzke JF Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983 ; 33: 1444-1452.
14. Alfano B., Brunetti A., Larobina M., et al. Automated segmentation and measurement of global white matter lesion volume in patients with multiple sclerosis. J Magn Reson Imaging 2000 ; 12: 799-807.
15. Good CD, Johnsrude IS, Ashburner J., Henson RN, Friston KJ, Frackowiak RS A voxel-based morphometric study of ageing in 465 normal adult human brains. Neuroimage 2001 ; 14: 21-36.
16. Friston KJ, Holmes AP, Poline JB, et al. Analysis of fMRI time-series revisited. Neuroimage 1995 ; 2: 45-53.
17. Ashburner J., Neelin P., Collins DL, Evans A., Friston K. Incorporating prior knowledge into image registration. Neuroimage 1997 ; 6: 344-352.
18. Woods RP, Grafton ST, Watson JD, Sicotte NL, Mazziotta JC Automated image registration: II. Intersubject validation of linear and nonlinear models. J Comput Assist Tomogr 1998 ; 22: 153-165.
19. Ashburner J., Friston KJ Nonlinear spatial normalization using basis functions. Hum Brain Mapp 1999 ; 7: 254-266.
20. Genovese CR, Lazar NA, Nichols T. Thresholding of statistical maps in functional neuroimaging using the false discovery rate. Neuroimage 2002 ; 15: 870-878.
21. Talairach J. and Tournoux P. Co-planar stereotaxic atlas of the human brain. 3-dimensional proportional system: an approach to cerebral imaging. Thieme, 1988. New York.
22. Bermel RA, Bakshi R. The measurement and clinical relevance of brain atrophy in multiple sclerosis. Lancet Neurol 2006 ; 5: 158-170. (Pubitemid 43107851)
23. Pagani E., Rocca MA, Gallo A., et al. Regional brain atrophy evolves differently in patients with multiple sclerosis according to clinical phenotype. Am J Neuroradiol 2005 ; 26: 341-346.
24. Henry RG, Shieh M., Okuda DT, Evangelista A., Gorno-Tempini ML, Pelletier D. Regional grey matter atrophy in clinically isolated syndromes at presentation. J Neurol Neurosurg Psychiatry 2008 ; 79: 1236-1244.
25. Wiegell MR, Tuch DS, Larsson HB, Wedeen VJ Automatic segmentation of thalamic nuclei from diffusion tensor magnetic resonance imaging. Neuroimage 2003 ; 19: 391-401.
26. De Stefano N., Matthews PM, Filippi M., et al. Evidence of early cortical atrophy in MS: relevance to white matter changes and disability. Neurology 2003 ; 60: 1157-1162.
27. Gasperini C., Paolillo A., Giugni E., et al. MRI brain volume changes in relapsing-remitting multiple sclerosis patients treated with interferon beta-1a. Mult Scler 2002 ; 8: 119-123. (Pubitemid 34256748)
28. Rudick RA, Fisher E., Lee JC, Duda JT, Simon J. Brain atrophy in relapsing multiple sclerosis: relationship to relapses, EDSS, and treatment with interferon beta-1a. Mult Scler 2000 ; 6: 365-372.
29. Zivadinov R., Sepcic J., Nasuelli D., et al. A longitudinal study of brain atrophy and cognitive disturbances in the early phase of relapsing-remitting multiple sclerosis. J Neurol Neurosurg Psychiatry 2001 ; 70: 773-780. (Pubitemid 32554208)
30. Tomaiuolo F., MacDonald JD, Caramanos Z., et al. Morphology, morphometry and probability mapping of the pars opercularis of the inferior frontal gyrus: an in vivo MRI analysis. Eur J Neurosci 1999 ; 11: 3033-3046.
31. Chiavaras MM, LeGoualher G., Evans A., Petrides M. Three-dimensional probabilistic atlas of the human orbitofrontal sulci in standardized stereotaxic space. Neuroimage 2001 ; 13: 479-496.
32. Rashid W., Davies GR, Chard DT, et al. Increasing cord atrophy in early relapsing-remitting multiple sclerosis: a 3 year study. J Neurol Neurosurg Psychiatry 2006 ; 77: 51-55. (Pubitemid 43022690)